FIGURE 2.

Prevalence of pldA in P. aeruginosa responsible for all type of infections (acute and chronic) (A) and acute infections (B) depending on the antimicrobial resistance phenotype. WT, wild-type phenotype; 1, resistance to one antimicrobial family, 2, resistance to two antimicrobial families; ≥3, resistance to three and more than three antimicrobial families. The antimicrobial families considered in the analysis were: penicillins (ticarcillin and piperacillin), broad-spectrum cephalosporins (ceftazidime and cefepime), carbapenems (imipenem and meropenem), fluroroquinolones (ciprofloxacine) and aminoglycosides (amikacin, tobramycin, and gentamicin). Raw numbers are indicated in side the bars. Statistical analysis was performed using χ² test for trend.